A Litany of Losses
The score looks dismal in week 13 in the life of the California Institute for Regenerative Medicine.
But the truly sad part about it is that much of the pain was unnecessary and is now hobbling an agency that was born with great expectations.
Here is a partial scorecard:
1. The agency now faces a potential ballot fight, possibly as early as next fall, if a…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.